Angioimmunoblastic T-cell lymphoma: Difference between revisions

Jump to navigation Jump to search
No edit summary
(Category)
 
(9 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Infobox_Disease |
  Name          = {{PAGENAME}} |
  Image          = |
  Caption        = |
  DiseasesDB    = |
  ICD10          = {{ICD10|C|84|4|c|81}} ([[ILDS]] C84.460)  |
  ICD9          = |
  ICDO          = 9705/3 |
  OMIM          = |
  MedlinePlus    = |
  eMedicineSubj  = |
  eMedicineTopic = |
  MeshID        = D007119 |
}}
{{Angioimmunoblastic T-cell lymphoma}}
{{Angioimmunoblastic T-cell lymphoma}}
{{CMG}}; {{AE}} {{RT}}


{{SK}} AILD-type (lymphogranulomatosis X) T-cell lymphoma; AILT; immunoblastic lymphadenopathy; Angioimmunoblastic lymphadenopathy with dysproteinemia.
'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''
 
{{CMG}}; {{AE}} {{AS}}
 
{{SK}} Immunoblastic lymphadenopathy; AILD-type T-cell lymphoma; Lymphogranulomatosis X T-cell lymphoma; AILD-type (lymphogranulomatosis X) T-cell lymphoma


==[[Angioimmunoblastic T-cell lymphoma overview|Overview]]==
==[[Angioimmunoblastic T-cell lymphoma overview|Overview]]==


==[[Angioimmunoblastic T-cell lymphoma historical perspective|Historical Perspective]]==
==[[Angioimmunoblastic T-cell lymphoma historical perspective|Historical Perspective]]==
==[[Angioimmunoblastic T-cell lymphoma classification|Classification]]==


==[[Angioimmunoblastic T-cell lymphoma pathophysiology|Pathophysiology]]==
==[[Angioimmunoblastic T-cell lymphoma pathophysiology|Pathophysiology]]==
Line 27: Line 18:
==[[Angioimmunoblastic T-cell lymphoma causes|Causes]]==
==[[Angioimmunoblastic T-cell lymphoma causes|Causes]]==


==[[Angioimmunoblastic T-cell lymphoma differential diagnosis|Differentiating Angioimmunoblastic T-cell lymphoma from other Diseases]]==
==[[Angioimmunoblastic T-cell lymphoma differential diagnosis|Differential Diagnosis]]==


==[[Angioimmunoblastic T-cell lymphoma epidemiology and demographics|Epidemiology and Demographics]]==
==[[Angioimmunoblastic T-cell lymphoma epidemiology and demographics|Epidemiology and Demographics]]==
Line 35: Line 26:
==[[Angioimmunoblastic T-cell lymphoma screening|Screening]]==
==[[Angioimmunoblastic T-cell lymphoma screening|Screening]]==


==[[Angioimmunoblastic T-cell lymphoma natural history|Natural History, Complications and Prognosis]]==


==Diagnosis==
==[[Angioimmunoblastic T-cell lymphoma natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
[[Angioimmunoblastic T-cell lymphoma history and symptoms|History and Symptoms ]] | [[ Angioimmunoblastic T-cell lymphoma physical examination|Physical Examination]] | [[Angioimmunoblastic T-cell lymphoma laboratory findings|Laboratory Findings]] | [[Angioimmunoblastic T-cell lymphoma chest x ray|Chest X Ray]] | [[Angioimmunoblastic T-cell lymphoma CT|CT]] | [[Angioimmunoblastic T-cell lymphoma MRI|MRI]] | [[Angioimmunoblastic T-cell lymphoma ultrasound|Ultrasound]] | [[Angioimmunoblastic T-cell lymphoma other imaging findings|Other Imaging Findings]] | [[Angioimmunoblastic T-cell lymphoma other diagnostic studies|Other Diagnostic Studies]]


== Diagnosis ==
[[Angioimmunoblastic T-cell lymphoma staging | Staging]] | [[Angioimmunoblastic T-cell lymphoma history and symptoms| History and Symptoms]] | [[Angioimmunoblastic T-cell lymphoma physical examination | Physical Examination]] | [[Angioimmunoblastic T-cell lymphoma laboratory tests| Laboratory Findings]] | [[Angioimmunoblastic T-cell lymphoma chest x ray|Chest X Ray]] | [[Angioimmunoblastic T-cell lymphoma CT|CT]] |  [[Angioimmunoblastic T-cell lymphoma MRI|MRI]] | [[Angioimmunoblastic T-cell lymphoma biopsy | Biopsy]] | [[Angioimmunoblastic T-cell lymphoma ultrasound | Ultrasound]] | [[Angioimmunoblastic T-cell lymphoma other imaging findings | Other Imaging Findings]] | [[Angioimmunoblastic T-cell lymphoma other diagnostic studies|Other Diagnostic Studies]]
==Treatment==
==Treatment==
[[Angioimmunoblastic T-cell lymphoma medical therapy|Medical Therapy]] | [[Angioimmunoblastic T-cell lymphoma surgery |Surgery]] | [[Angioimmunoblastic T-cell lymphoma primary prevention|Primary Prevention]] | [[Angioimmunoblastic T-cell lymphoma secondary prevention|Secondary Prevention]] | [[Angioimmunoblastic T-cell lymphoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Angioimmunoblastic T-cell lymphoma future or investigational therapies|Future or Investigational Therapies]]
 
[[Angioimmunoblastic T-cell lymphoma medical therapy| Medical Therapy]] | [[Angioimmunoblastic T-cell lymphoma surgery| Surgery]] | [[Angioimmunoblastic T-cell lymphoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Angioimmunoblastic T-cell lymphoma future or investigational therapies|Future or Investigational Therapies]]


==Case Studies==
==Case Studies==
Line 47: Line 40:
[[Angioimmunoblastic T-cell lymphoma case study one|Case #1]]
[[Angioimmunoblastic T-cell lymphoma case study one|Case #1]]


==References==
{{Tumors}}
{{reflist|2}}


 
[[Category:Disease]]
{{Hematological malignancy histology}}
 
[[Category:Hematology]]
[[Category:Types of cancer]]
[[Category:Types of cancer]]
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Disease]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Hematology]]
[[Category:Immunology]]

Latest revision as of 03:13, 24 October 2017

Angioimmunoblastic T-cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Angioimmunoblastic T-cell lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Biopsy

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Angioimmunoblastic T-cell lymphoma On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Angioimmunoblastic T-cell lymphoma

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Angioimmunoblastic T-cell lymphoma

CDC on Angioimmunoblastic T-cell lymphoma

Angioimmunoblastic T-cell lymphoma in the news

Blogs on Angioimmunoblastic T-cell lymphoma

Directions to Hospitals Treating Angioimmunoblastic T-cell lymphoma

Risk calculators and risk factors for Angioimmunoblastic T-cell lymphoma

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]

Synonyms and keywords: Immunoblastic lymphadenopathy; AILD-type T-cell lymphoma; Lymphogranulomatosis X T-cell lymphoma; AILD-type (lymphogranulomatosis X) T-cell lymphoma

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differential Diagnosis

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Biopsy | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Template:Tumors


Template:WikiDoc Sources